Press Releases

NEW ORLEANS, Oct. 14, 2019 /PRNewswire/ -- ­­Vaping is not a low-risk substitute for smoking cigarettes, according to researcher Charlie Lin, MD, who authored a case study of a 34-year-old former smoker diagnosed with granulomatosis attributed to two months of electronic cigarette use. Dr. Lin will present his case study at the CHE

NEW ORLEANS, Oct. 14, 2019 /PRNewswire/ -- Patients newly diagnosed with pulmonary arterial hypertension (PAH) treated with macitentan and tadalafil combination therapy showed hemodynamic progress, as well as improvements in function and risk profile, according to Olivier Sitbon, MD, PhD, from Université Paris–Sud, who will pr

NEW ORLEANS, Oct. 14, 2019 /PRNewswire/ -- There is nearly a 40% chance of overdiagnosing chronic obstructive pulmonary disease (COPD) when spirometry is not combined with bronchodilator (BD) testing, often missing asthma and asthma-COPD overlap syndrome (ACOS), according to Srinadh Annangi, MD, from the University of Kentucky, School of Medi

NEW ORLEANS, Oct. 14, 2019 /PRNewswire/ -- The long-acting bronchodilator aclidinium bromide (AB) is safe for patients at increased risk for heart attack and stroke and reduces the risk of new exacerbations in people with chronic obstructive pulmonary disease (COPD), regardless of whether they have had an exacerbation in the preceding year, according to

HOUSTON and LOS ALTOS, Calif., Oct. 14, 2019 /PRNewswire/ -- Univfy®, an AI platform company whose mission is to improve fertility patients' experience a

PALO ALTO, Calif., Oct. 14, 2019 /PRNewswire/ -- Varian (NYSE: VAR) in collaboration with Cincinnati Children's Hospital Medical Center/University of Cincinnati Medical Center Proton Therapy Center announced the achievement of a significant milestone in the path towards clinical trials of FLASH therapy*. The combined research team utilized a

DEERFIELD BEACH, Fla., Oct. 14, 2019 /PRNewswire/ -- Bongo® Rx, an FDA cleared medical device for the treatment of mild to moderate obstructive sleep apnea, utilizes no electricity or batteries. This cutting edge medical technology reduces the carbon footprint in the battle against global warming as no fossil fuels are consumed to power the device du

MINNEAPOLIS, Oct. 14, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), a leading physician-founded, science-focused multi-state cannabis company, today announced the promotion of Chief Operating Officer ­Ari Hoffnung to the newly created role of Chief Strategy Officer. Mr. Hoffnung also serves on Vireo's Bo

MENLO PARK, Calif., Oct. 14, 2019 /PRNewswire/ -- Drawbridge Health, creators of the revolutionary OneDraw™ A1C Test System, today announced new management appointments, including the promotions of Elisa Romeo and Greg Nagy as well as the addition of Kamraan Shariff.

NEW YORK, Oct. 14, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and chronic wound disorders, today announced that the company has made a donation to the National Ec